Gyre Therapeutics (GYRE) Treasury Shares (2011 - 2019)

Gyre Therapeutics (GYRE) has 9 years of Treasury Shares data on file, last reported at $1.6 million in Q4 2019.

• Quarterly Treasury Shares changed N/A year-over-year to $1.6 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $1.6 million (changed N/A YoY) and the FY2019 annual result came in at $1.6 million, changed N/A from the prior year.
• Treasury Shares was little changed at $1.6 million in Q4 2019 per GYRE's latest filing, from $1.6 million in the prior quarter.
• Across five years, Treasury Shares topped out at $1.6 million in Q2 2019 and bottomed at $44704.0 in Q1 2017.
• The 5-year median for Treasury Shares is $1.0 million (2018), against an average of $975708.1.
• The widest annual swing landed in 2015, when Treasury Shares slumped 79.89%; it then jumped 2195.98% in 2018.
• Tracing GYRE's Treasury Shares over 5 years: stood at $103129.0 in 2015, then jumped by 36.71% to $140990.0 in 2016, then jumped by 482.84% to $821741.0 in 2017, then soared by 60.53% to $1.3 million in 2018, then rose by 19.59% to $1.6 million in 2019.
• Per Business Quant, the three latest GYRE Treasury Shares figures stand at $1.6 million (Q4 2019), $1.6 million (Q3 2019), and $1.6 million (Q2 2019).

Peer Comparison